Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News

Sign in

Welcome!Log into your account

your username

your password

Forgot your password?

Password recovery

Recover your password

your email

Search

Sign in

Welcome! Log into your account

your username

your password

Forgot your password? Get help

Password recovery

Recover your password

your email

A password will be e-mailed to you.

BioPharmaJournal

Home
Contact Us
About Us
Advertise
Biotech
- $Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For Refractory/Relapsed Multiple Myeloma$
  Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For…
  Atara Biotherapeutics Inc. (NASDAQ:ATRA) Reports Phase 1a ATA188 Data With Progressive…
  MediciNova Inc. (NASDAQ:MNOV) Reports Promising Results Of Its Intranasal BC-PIV SARS-CoV-2…
  Oncova Therapeutics Inc. (NASDAQ:ONTX) Commence Phase 1 ON 123300 Study In…
  Sorento Therapeutics Inc. (NASDAQ:SRNE) Report Encouraging Phase 1B Resiniferatixin (RTX) Study…
Finance
- Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical…
  OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply…
  TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence…
  British Journal of Haematology Publishes Post-Hoc Analysis of Tavalisse for Adults…
  Equillium Inc (NASDAQ:EQ) Reports Favorable Results From itolizumab Clinical Trials
Tech News
- Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
  Micro and Macro Tailwinds Converge for KULR
  ISWH and the Rebirth of the Crypto Cycle

Home Advertise

Advertise

BioPharmaJournal.com has a strong base of loyal readers. To advertise with us please email us at [email protected]

Home
Contact Us
About Us
Advertise
Biotech
- $Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For Refractory/Relapsed Multiple Myeloma$
  Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For…
  Atara Biotherapeutics Inc. (NASDAQ:ATRA) Reports Phase 1a ATA188 Data With Progressive…
  MediciNova Inc. (NASDAQ:MNOV) Reports Promising Results Of Its Intranasal BC-PIV SARS-CoV-2…
  Oncova Therapeutics Inc. (NASDAQ:ONTX) Commence Phase 1 ON 123300 Study In…
  Sorento Therapeutics Inc. (NASDAQ:SRNE) Report Encouraging Phase 1B Resiniferatixin (RTX) Study…
Finance
- Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical…
  OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply…
  TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence…
  British Journal of Haematology Publishes Post-Hoc Analysis of Tavalisse for Adults…
  Equillium Inc (NASDAQ:EQ) Reports Favorable Results From itolizumab Clinical Trials
Tech News
- Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
  Micro and Macro Tailwinds Converge for KULR
  ISWH and the Rebirth of the Crypto Cycle

© BioPharma Journal 2020

.td-post-views{ display: none !important; }